--- title: "Spero Therap (SPRO.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/SPRO.US/norm.md" symbol: "SPRO.US" name: "Spero Therap" parent: "https://longbridge.com/en/quote/SPRO.US.md" datetime: "2026-06-19T12:05:26.058Z" locales: - [en](https://longbridge.com/en/quote/SPRO.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/SPRO.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/SPRO.US/norm.md) --- # Spero Therap (SPRO.US) — Financial Reports ## Income Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | EPS | -0.1257 | 0.5357 | -0.1312 | -0.0303 | -0.2504 | | ROE | -51.47% | 294.87% | -99.55% | -20.41% | -138.77% | | Revenue | 258000.00 | 41.30M | 5.44M | 14.19M | 5.87M | | Net income | -7.20M | 31.52M | -7.38M | -1.70M | -13.87M | | Operating income | -7.54M | 31.41M | -7.33M | -2.36M | -14.56M | | Gross margin | -1027.52% | 86.46% | -57.98% | 24.79% | -131.63% | | Net margin | -2791.86% | 76.33% | -135.65% | -11.98% | -236.06% | | Profit quality | -47.52% | -376.06% | -42.07% | - | - | ## Balance Sheet (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | A&L | 59.02M | 68.92M | 54.17M | 62.12M | 77.71M | | Leverage | 1.11 | 1.17 | 2.04 | 1.89 | 2.30 | | BVPS | 0.9144 | 1.05 | 0.4705 | 0.5843 | 0.6049 | | Turnover | 0.8950 | 0.7445 | 0.4283 | 0.4583 | 0.3633 | | Cash & STI | 56.13M | 40.27M | 48.62M | 31.19M | 48.89M | | Inv & Rec | - | - | - | - | - | | LT assets | 1.26M | 1.48M | 1.69M | 2.56M | 2.84M | | Net debt | -53.66M | -37.37M | -45.27M | -27.58M | -44.93M | ## Cash Flow Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | Operating CF | 15.86M | -8.35M | 17.42M | -17.69M | -4.00M | | Investing CF | - | - | - | - | - | | Financing CF | - | - | - | - | - | | Free CF | 18.55M | -7.52M | 19.62M | -17.40M | 1.05M | | OCF coverage | - | - | - | - | - | | Repaid & issued | - | - | - | - | - | | CapEx | - | - | - | - | - |